Regenxbio Inc (RGNX)
7.63
+0.22
(+2.97%)
USD |
NASDAQ |
Dec 20, 16:00
7.71
+0.08
(+1.05%)
After-Hours: 20:00
Regenxbio Market Cap: 378.03M for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Catalyst Pharmaceuticals Inc | 2.537B |
Vertex Pharmaceuticals Inc | 102.31B |
Sarepta Therapeutics Inc | 11.36B |
Edgewise Therapeutics Inc | 2.911B |
Entrada Therapeutics Inc | 658.59M |
Market Cap Related Metrics
PS Ratio | 4.324 |
Price to Book Value | 1.254 |
Price | 7.63 |
Earnings Yield | -65.79% |